QIV

· Wuhan Institute of Biological Products Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QIV, covering 2022-05-25 to 2022-05-25. Get the full timeline:

Most recent: Clinical Trial Update: To Identify the Immunogenicity and Safety of QIV in Children Aged 3-8 Years [Phase 4]